Fiera Capital Corp Amicus Therapeutics, Inc. Transaction History

Fiera Capital Corp

  • $30.3 Billion
  • Q4 2024

A detailed history of Fiera Capital Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Fiera Capital Corp holds 3,037,248 shares of FOLD stock, worth $29.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,037,248
Previous 3,212,561 5.46%
Holding current value
$29.7 Million
Previous $34.3 Million 16.61%
% of portfolio
0.09%
Previous 0.11%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$9.36 - $12.01 $1.64 Million - $2.11 Million
-175,313 Reduced 5.46%
3,037,248 $28.6 Million
Q3 2024

Nov 01, 2024
SELL
$9.55 - $12.09 $19.7 Million - $25 Million
-2,067,881 Reduced 39.16%
3,212,561 $34.3 Million
Q2 2024

Aug 01, 2024
BUY
$9.04 - $11.75 $525,341 - $682,827
58,113 Added 1.11%
5,280,442 $52.4 Million
Q1 2024

Aug 22, 2024
SELL
$11.43 - $14.24 $664,231 - $827,529
-58,113 Reduced 1.1%
5,222,329 $61.5 Million
Q1 2024

May 01, 2024
BUY
$11.43 - $14.24 $1.84 Million - $2.29 Million
160,685 Added 3.17%
5,222,329 $61.5 Million
Q4 2023

Aug 22, 2024
SELL
$9.97 - $14.52 $241,543 - $351,776
-24,227 Reduced 0.48%
5,061,644 $71.8 Million
Q4 2023

Feb 08, 2024
SELL
$9.97 - $14.52 $241,543 - $351,776
-24,227 Reduced 0.48%
5,061,644 $71.8 Million
Q3 2023

Aug 22, 2024
SELL
$11.78 - $13.86 $2.29 Million - $2.7 Million
-194,571 Reduced 3.68%
5,085,871 $61.8 Million
Q3 2023

Nov 09, 2023
BUY
$11.78 - $13.86 $1.25 Million - $1.47 Million
106,086 Added 2.13%
5,085,871 $61.8 Million
Q2 2023

Aug 09, 2023
SELL
$10.72 - $13.3 $1.3 Million - $1.62 Million
-121,579 Reduced 2.38%
4,979,785 $62.5 Million
Q1 2023

Apr 26, 2023
SELL
$10.91 - $13.54 $957,821 - $1.19 Million
-87,793 Reduced 1.69%
5,101,364 $56.6 Million
Q4 2022

Feb 08, 2023
BUY
$9.89 - $12.7 $11.6 Million - $14.9 Million
1,172,602 Added 29.19%
5,189,157 $63.4 Million
Q3 2022

Nov 03, 2022
SELL
$9.82 - $12.75 $651,232 - $845,541
-66,317 Reduced 1.62%
4,016,555 $38.1 Million
Q2 2022

Aug 10, 2022
SELL
$6.23 - $11.12 $460,247 - $821,501
-73,876 Reduced 1.78%
4,082,872 $43.9 Million
Q1 2022

May 09, 2022
BUY
$7.89 - $12.48 $1.23 Million - $1.95 Million
155,907 Added 3.9%
4,156,748 $39.4 Million
Q4 2021

Feb 08, 2022
BUY
$9.82 - $12.44 $9.19 Million - $11.6 Million
936,234 Added 30.55%
4,000,841 $46.2 Million
Q3 2021

Nov 12, 2021
SELL
$8.74 - $11.84 $474,695 - $643,065
-54,313 Reduced 1.74%
3,064,607 $29.3 Million
Q2 2021

Aug 11, 2021
SELL
$8.71 - $10.72 $762,734 - $938,750
-87,570 Reduced 2.73%
3,118,920 $47 Million
Q1 2021

May 11, 2021
BUY
$9.2 - $23.86 $29.5 Million - $76.5 Million
3,206,490 New
3,206,490 $31.7 Million

Others Institutions Holding FOLD

# of Institutions
317
Shares Held
315M
Call Options Held
530K
Put Options Held
569K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.74B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email